Outreach & News

August 2015:

SEA Blue pre-event interview with Tom Kirk, Us TOO President & CEO, on US99.5 FM

May 2015:

Interviews with Tom Kirk, Us TOO President & CEO, on Chicago radio stations:
96.3FM B96; Saturday, May 9
104.3FM KHITS; Sunday, May 10



September 2014:

ABC-7 Eyewitness News television coverage of 10th Annual SEA Blue Chicago Prostate Cancer Walk & Run featuring Tom Kirk and prostate cancer survivor Jim Schraidt.

Podcast with Tom Kirk from “Frankly Speaking about Cancer,” a weekly radio show from Cancer Support Community.

PCRI Insights magazine article about Us TOO board member Jerry Deans sharing his story as a prostate cancer survivor and support group participant.

Naperville Sun features story about Cliff Whall and his experience managing prostate cancer with the support of his wife, Monique Davoust.

August 2014: Stanford Medicine, in partnership with Inspire, featured a blog post from Us TOO Chairman of the Board Jim Rieder.

June 2014: Cure Panel Talk Show radio segment on clinical trials in prostate cancer featuring Dr. Ian Thompson and discussion panelists Mike Scott, Paul Carpenter, Jan Manerite and Tom Kirk.

March 2014: Cure Panel BlogTalk radio segment on prostate cancer active surveillance with information for men dealing with low-grade localized prostate cancer features Laurence Klotz, MD, Tom Kirk and several very active members of the prostate cancer community including Mike Scott, Tony Crispino and Walter Green.

February 2014: Bone health New York satellite media tour featuring Dr. David Henry and Tom Kirk on 961 radio and television stations including KARD FOX MonroeKMTV CBS OmahaKOB NBC New Mexico; and Philadelphia radio station WCHE-AM

February 2014: A brief video on http://www.psadebate.com/ features Dr. Mark Scholz citing results from the survey of 1,539 men from Theragenics’ 2013 PSA awareness research, which was conducted in response to the USPSTF and other controversial PSA guidelines.

 

 

 

CLICK HERE and opt-in to receive free educational emails from Us TOO.